Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSONG.L Regulatory News (SONG)

  • There is currently no data for SONG

Statement re: final offer for Hipgnosis

9 May 2024 07:00

RNS Number : 6739N
Alchemy Copyrights, LLC
09 May 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

FOR IMMEDIATE RELEASE

9 May 2024

CONCORD CHORUS LIMITED ("CONCORD BIDCO")

STATEMENT REGARDING FINAL OFFER FOR

HIPGNOSIS SONGS FUND LIMITED ("HIPGNOSIS")

 

Further to the announcements made by Concord Bidco on 18 April 2024 and 24 April 2024 (the "Announcements") setting out the terms of its all cash offer for the entire issued, and to be issued, share capital of Hipgnosis, Concord Bidco confirms that its offer of $1.25 per Hipgnosis Share is final and will not be increased.

Capitalised terms used in this announcement, unless otherwise defined, shall have the meanings given to them in the Rule 2.7 Announcement.

Enquiries:

Concord

+1 629 401 3906

Kelly Voigt (SVP, Corporate Communications)

 

 

 

Apollo

+44 20 7016 5000

Erin Clark

 

 

 

J.P. Morgan Cazenove (Sole Financial Adviser to Concord Bidco)

Jonty Edwards

Rupert Budge

Edward Hatter

Greg Slack

 

+44 203 493 8000

H/Advisors Maitland (PR Adviser to Concord Bidco)

Neil Bennett

Jonathan Cook

 

+44 7900 000777

+44 7730 777865

 

Important notices

J.P. Morgan Securities LLC together with its affiliate J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove and which is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the FCA (together, "J.P. Morgan Cazenove") is acting as financial adviser exclusively to Concord Bidco and no one else in connection with the Acquisition and will not regard any other person as their client in relation to the Acquisition and will not be responsible to anyone other than Concord Bidco for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

This Announcement is for information purposes only and is not intended to and does not constitute, or form part of, an offer to sell or an invitation to purchase any securities or a solicitation of an offer to buy, otherwise acquire, subscribe for, sell or otherwise dispose of any securities pursuant to the Acquisition or otherwise, nor shall there be any purchase, sale, issuance or exchange of securities or such solicitation in any jurisdiction in which such offer, invitation, solicitation, purchase, sale, issuance or exchange is unlawful.

No person should construe the contents of this Announcement as legal, financial or tax advice. If you are in any doubt about the contents of this Announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or from an independent financial adviser duly authorised under FSMA if you are resident in the United Kingdom, or another appropriately authorised independent financial adviser, if you are in a territory outside the United Kingdom.

Overseas Shareholders

This Announcement has been prepared for the purpose of complying with Guernsey law, English law, the Takeover Code, the Market Abuse Regulation, the Disclosure Guidance and Transparency Rules and the Listing Rules and information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom or Guernsey. Nothing in this Announcement should be relied on for any other purpose.

Publication of this Announcement on websites and availability of hard copies

A copy of this Announcement and the documents required to be published pursuant to Rules 26.1 and 26.2 of the Takeover Code will be available, free of charge, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on https://communications.singercm.com/p/4UWI-ETV/recommended-cash-offer-hipgnosis and Concord Bidco's website at www.projectchorus.com by no later than 12.00 p.m. on the Business Day following the date of this Announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGGKKRRGDZM
Date   Source Headline
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration
16th May 20237:00 amRNSCorrection of Director/PDMR Shareholding
15th May 20234:32 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSDirectorate Change
16th Mar 20237:00 amRNSDividend Declaration
10th Mar 20235:00 pmRNSDirector/PDMR Shareholding
10th Mar 20234:50 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSTotal Voting Rights
23rd Dec 202211:53 amRNSPublication of Factsheet
13th Dec 20224:03 pmRNSHoldings in Company-Notification of Major Holdings
8th Dec 20227:01 amRNSDividend Declaration
8th Dec 20227:00 amRNSHalf-year Report
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 202210:05 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSNotice: Half Year Results and Capital Markets Day
24th Nov 20226:06 pmRNSHolding(s) in Company
18th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20223:29 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:01 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:35 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20223:16 pmRNSReplacement Transaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSShare Repurchase Programme
10th Oct 20224:41 pmRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSHipgnosis Songs Fund announces interest rate hedge
3rd Oct 20227:00 amRNSHipgnosis Songs Fund announces debt refinancing
21st Sep 20222:59 pmRNSResult of Fourth AGM
21st Sep 20227:00 amRNSDividend Declaration
12th Sep 20224:42 pmRNSRevised Voting by Proxy Deadline
2nd Sep 20224:44 pmRNSHolding(s) in Company
8th Aug 20224:12 pmRNSHolding(s) in Company
3rd Aug 20227:00 amRNSNotice of Annual General Meeting
14th Jul 20227:01 amRNSNew Administration Agreements - Sacem & peermusic
14th Jul 20227:00 amRNSAnnual Financial Report
13th Jul 20227:00 amRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSImpact of Copyright Royalty Board III Decision
12th May 20227:00 amRNSDividend Declaration
13th Apr 202212:05 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSKepler Trust Intelligence: New Research
8th Feb 20227:00 amRNSDividend Declaration
16th Dec 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.